Athletes dealing with multiple minor injuries, post-surgical patients with systemic inflammation, or anyone needing general tissue regeneration support can benefit from a single injection reaching multiple problem areas simultaneously
For three decades, BPC-157 has been one of the most talked-about peptides in research and biohacking circles and yet, as of early 2026, not a single properly controlled human trial had been completed
Gastrointestinal disorders: mild transient diarrhea
The company's choice of arginate salt reflects this research literature
In this case, insurance does cover treatment
Research confirms BPC-157 naturally migrates toward areas of tissue damage, making it somewhat self-directing in its therapeutic action